FDA issued a Warning Letter to Windlas Healthcare Private Limited on 3/10/2020 for a later inspection.
483 Windlas Healthcare Private Jun 2014

483 Windlas Healthcare Private Jun 2014

$119 - Not in Stock

FDA investigators audited the Windlas Healthcare Private - Dehradun, India facility and issued inspectional observations (via FDA 483) on 13 Jun 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Jun 2014
  • Location: Dehradun, India
  • FEI: 3005339091

Pre-Order Not Available